DOAC Exposure in Early Pregnancy and Risk of Birth Defects – JTH
Journal of Thrombosis and Haemostasis shared a post on LinkedIn about a recent article by Kim Dao et al, adding:
”Reproductive safety of direct oral anticoagulants after maternal exposure in early pregnancy: a comparative European Network of Teratology Information Services cohort study
This prospective observational cohort compared 343 pregnancies with first-trimester DOAC exposure and 698 with low-molecular-weight heparin exposure.
Major birth defects occurred in 8/279 (2.9%) and 25/586 (4.3%) evaluable pregnancies, respectively; the adjusted odds ratio was 0.74 (95% CI, 0.33–1.67).
No increased pregnancy-loss risk was detected.
The findings offer reassurance for counseling after inadvertent early exposure, with remaining uncertainty from sample size and exposure duration.
They do not establish DOAC safety for continued use during pregnancy.”
Title: Reproductive safety of direct oral anticoagulants after maternal exposure in early pregnancy: a comparative European Network of Teratology Information Services cohort study
Authors: Kim Dao, Evelin Beck, Veronique Pizzoglio-Billaudaz, Judith Cottin, Svetlana Shechtman, Orna Diav-Citrin, Reem Murad, Maria Moran, Debra Kennedy, Jonathan Luke Richardson, Maja Ratajczak-Enselme, Kuntheavy Ing Lorenzini, Miranda van Tuyl, Petra J. Woestenberg, Georgios Eleftheriou, Mikako Goto, Izumi Fujioka, Laurent Chouchana, Katarina Dathe, Maya Berlin, Michael Ceulemans, Lina Camacho-Arteaga, Valentin Rousson, Leonore Diezi, David Baud, Joanna Sichitiu, Stephanie Padberg, Alice Panchaud, Ursula Winterfeld, Maria Hoeltzenbein

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 22, 2026, 13:45Ahmad Gharehbaghian: Football and Blood Donation Unite for a Humanitarian Cause
-
Nov 22, 2026, 13:34Pranvera Ibrahimi: Where Cardiology Meets Neurology in Stroke Prevention
-
Nov 22, 2026, 13:17Amirreza Sabahizadeh: A Closer Look at Stroke Prevention Strategies in AF
-
Nov 22, 2026, 13:13Peter Loffelhardt: Day 1 Sessions of the 6th Global MPN Symposium Now Available Online
-
Nov 22, 2026, 13:01Marko Lucijanic: The ZEBRA Score A New Tool for Predicting Thrombotic Risk in Myelofibrosis
-
Nov 22, 2026, 12:58Saiyed raza Abbas: Understanding White Blood Cell Development and Maturation in Peripheral Blood Smears
-
Nov 22, 2026, 12:46Rui Providência: Anticoagulation After AF Ablation A Timely Discussion
-
Nov 22, 2026, 12:41Teresa Gerardi: KIT Inhibition with Avapritinib and Its Potential Impact on Mastocytosis-Related Osteoporosis
-
Nov 22, 2026, 12:37Rahul Bhargava: 2026 Haematology’s Shift From Chemotherapy to Immunotherapy